Molecular Diagnostics
Predicting Cancer Relapse Improved by High-Throughput DNA Sequencing
Researchers have shown that high-throughput sequencing detects the earliest known signs of potential cancer relapse faster and in nearly twice the number of leukemia patients as flow cytometry, the current gold standard for detecting minimal residual disease. More...14 Jun 2012
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Hematology System
Medonic M16C
Laboratory Software
ArtelWare
In Other News
Novel Microbe Biomarkers Reveal Evidence of Radiation Exposure
Biomarkers Discovered for Bowel Cancer Blood Test
RNA Expression Measured In Tissue Sections
Identification of Abnormal Oocyte Should Improve IVF Success Rates
Single Test Detects All Existing Strains of H5N1
Distinct Molecular Subtype of Prostate Cancer Discovered
Biomarkers Discovered for Prostate Cancer Detection and Recurrence
Biosignatures Distinguish Between Fatal Lung Diseases
Noninvasive Prenatal Test Launched
Plastic Chip Identifies DNA Sequences in Drop of Blood
Genetic Testing Service Introduced for Amyotrophic Lateral Sclerosis
Next Generation Digital PCR System Launched
Nonsurgical Test Developed For Brain Cancer
Molecular Methods Differentiate Breast Cancers
Urinary Test Score Unchanged by Chronic Prostatitis
Noninvasive Stool Test Biased by Patient's Age
Genetic Abnormality Discovered for Brain Cancer
Genomic Test Spares Cancer Patients Chemotherapy
Blood Test Inaugurated for Early Detection of Lung Cancer
Molecular Analysis Used to Identify Specific Cancers
Biomolecular System Launched for Proteins Quantitation
Genetic Mutation Discovered in Familial Chronic Diarrhea Syndrome
Biomarker Links Clinical Outcome of Lethal Tumor Metabolism
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
